Medical Equipment

Intranasal Drug Delivery Devices Market Future Outlook Showing Expansion Toward $99.11 Billion by 2030

March 12, 2026March 12, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Intranasal Drug Delivery Devices Market Expected To Change Between 2026 And 2030?

The intranasal drug delivery devices market size has shown significant expansion in recent years. It is anticipated to increase from $65.09 billion in 2025 to $70.77 billion in 2026, registering a compound annual growth rate (CAGR) of 8.7%. The historical growth of this market is attributable to the growing occurrence of respiratory and nasal disorders, the increasing adoption of the nasal route for systemic drug delivery, the rise of self-administration drug devices, an increase in approvals for intranasal therapies, and the expansion of outpatient treatment models.

The intranasal drug delivery devices market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $99.11 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.8%. This projected growth is driven by factors such as the increasing creation of biologics and vaccines for nasal administration, a surging need for home-based drug delivery, broader application of intranasal methods for neurological treatments, escalating investments in sophisticated drug-device innovations, and a heightened emphasis on solutions that improve patient adherence. Key trends anticipated during this period encompass the wider embrace of precision nasal delivery systems, an escalating preference for non-invasive drug application, the advancement of multi-dose nasal devices, a diversification of patient-friendly drug delivery formats, and a sharper focus on achieving swift drug absorption.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13463&type=smp

What Drivers Are Expected To Influence The Intranasal Drug Delivery Devices Market During The Forecast Period?

The growing occurrence of chronic ailments is projected to boost the expansion of the intranasal drug delivery devices market in the future. These are health conditions enduring a year or longer, necessitating continuous medical care, restricting daily activities, or both. Intranasal drug delivery systems offer a non-invasive and effective method for administering medicines, thus aiding in the management of chronic diseases. Such devices facilitate direct delivery of drugs to the target region, offering convenience, ease of use, and quick absorption. As an illustration, data from June 2024, released by the National Health Service, a UK-based government department, revealed that in 2023, the population in England vulnerable to type 2 diabetes climbed to 3,615,330, an increase from 3,066,330 in 2022. This included an identification of more than 549,000 extra individuals with non-diabetic hyperglycemia, also known as pre-diabetes. Consequently, the rising incidence of chronic illnesses is fueling the expansion of the intranasal drug delivery devices market.

How Is The Intranasal Drug Delivery Devices Market Structured Across Different Segments?

The intranasal drug delivery devices market covered in this report is segmented –

1) By Product: Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products

2) By Dosage: Unit-Dose, Multi-Dose

3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications

4) By End User: Hospitals, Clinics, Homecare, Other End Users

Subsegments:

1) By Powder Delivery Device: Single-Dose Powder Device, Multi-Dose Powder Device

2) By Liquid Delivery Device: Single-Dose Liquid Device, Multi-Dose Liquid Device

3) By Pressurized Metered-Dose Inhalers (pMDIs): Breath-Actuated PMDIs, Conventional pMDIs

4) By Other Products: Gel Delivery Device, Nebulizers, Nasal Sprays

Which Trends Are Shaping The Future Of The Intranasal Drug Delivery Devices Market?

Major companies in the intranasal drug delivery devices market are concentrating on creating innovative and improved products, such as recyclable polyolefin nasal spray actuators, to boost sustainability, enhance patient compliance, and support environmentally sound drug delivery solutions. A recyclable polyolefin nasal spray actuator constitutes a nasal drug delivery component made entirely from polyolefin materials, designed for multiple-dose administration without any metal parts. For instance, in January 2023, Aptar Pharma, a US-based drug delivery and pharmaceutical solutions company, introduced the APF Futurity, the first metal-free multidose nasal spray pump engineered to address the increasing demand for highly recyclable packaging. The APF Futurity is composed entirely of polyolefin materials, contains no metal components, and holds a Class AA highly recyclable certification from cyclos-HTP. This pump offers precise and consistent dosing with gentle actuation, is compatible with nasal saline and other over-the-counter formulations, and facilitates sustainable recycling, making it ideal for environmentally conscious drug delivery solutions and patient convenience.

Which Major Players Dominate The Intranasal Drug Delivery Devices Market?

Major companies operating in the intranasal drug delivery devices market are Johnson and Johnson Inc., Novartis AG, AstraZeneca plc., GlaxoSmithKline Plc, 3M Company, Becton Dickinson and Company, Teva Pharmaceutical Industries Ltd., AptarGroup Inc., West Pharmaceutical Services Inc., Recipharm AB, Nemera Development S.A., Consort Medical plc., Vectura Group plc., OptiNoset Inc., Flamel Technologies, Aegis Therapeutics LLC, PendoPharm Inc., Kurve Technology Inc., Impel NeuroPharma, Impexium Medical Products, ENT Technologies Pty. Ltd., Neurelis Inc.

Read the full intranasal drug delivery devices market report here:

https://www.thebusinessresearchcompany.com/report/intranasal-drug-delivery-devices-global-market-report

Which Region Is Forecast To Lead The Intranasal Drug Delivery Devices Market In Terms Of Market Size?

North America was the largest region in the intranasal drug delivery devices market in 2025. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Intranasal Drug Delivery Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13463&type=smp

Browse Through More Reports Similar to the Global Intranasal Drug Delivery Devices Market 2026, By The Business Research Company

Nail Salon Market Report 2026

https://www.thebusinessresearchcompany.com/report/nail-salon-global-market-report

Nail Polish Market Report 2026

https://www.thebusinessresearchcompany.com/report/nail-polish-global-market-report

Medical Tubing Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-tubing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795